Search by Drug Name or NDC

    NDC 00054-0141-20 Acarbose 50 mg/1 Details

    Acarbose 50 mg/1

    Acarbose is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is ACARBOSE.

    Product Information

    NDC 00054-0141
    Product ID 0054-0141_68881739-6edb-4c67-be06-14953f60a146
    Associated GPIs 27500010000320
    GCN Sequence Number 020242
    GCN Sequence Number Description acarbose TABLET 50 MG ORAL
    HIC3 C4M
    HIC3 Description ANTIHYPERGLYCEMIC, ALPHA-GLUCOSIDASE INHIBITORS
    GCN 02319
    HICL Sequence Number 008283
    HICL Sequence Number Description ACARBOSE
    Brand/Generic Generic
    Proprietary Name Acarbose
    Proprietary Name Suffix n/a
    Non-Proprietary Name Acarbose
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 50
    Active Ingredient Units mg/1
    Substance Name ACARBOSE
    Labeler Name Hikma Pharmaceuticals USA Inc.
    Pharmaceutical Class alpha Glucosidase Inhibitors [MoA], alpha-Glucosidase Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078470
    Listing Certified Through 2024-12-31

    Package

    NDC 00054-0141-20 (00054014120)

    NDC Package Code 0054-0141-20
    Billing NDC 00054014120
    Package 10 BLISTER PACK in 1 CARTON (0054-0141-20) / 10 TABLET in 1 BLISTER PACK
    Marketing Start Date 2008-05-07
    NDC Exclude Flag N
    Pricing Information N/A